Goldman Sachs
OM icon

Goldman Sachs’s Outset Medical OM Stock Holding History

Goldman Sachs’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$749K Buy
173,460
+80,100
+86% +$350K ﹤0.01% 5436
2026
Q1 		$359K Buy
93,360
+20,662
+28% +$84.7K ﹤0.01% 5791
2025
Q4 		$270K Buy
72,698
+1,368
+2% +$11.7K ﹤0.01% 5916
2025
Q3 		$1.01M Sell
71,330
-20,792
-23% -$324K ﹤0.01% 5011
2025
Q2 		$1.77M Buy
+92,122
New +$1.44M ﹤0.01% 4270
2025
Q1 		– Sell
-5,451
Closed -$90.8K – 6319
2024
Q4 		$90.8K Buy
5,451
+4,717
+643% +$58.9K ﹤0.01% 5779
2024
Q3 		$7.45K Sell
734
-44,484
-98% -$1.32M ﹤0.01% 5713
2024
Q2 		$2.61M Buy
45,218
+23,475
+108% +$1.15M ﹤0.01% 3728
2024
Q1 		$724K Buy
21,743
+5,889
+37% +$298K ﹤0.01% 4540
2023
Q4 		$1.29M Buy
15,854
+10,855
+217% +$883K ﹤0.01% 4238
2023
Q3 		$816K Sell
4,999
-1,879
-27% -$444K ﹤0.01% 4399
2023
Q2 		$2.26M Sell
6,878
-1,177
-15% -$359K ﹤0.01% 3787
2023
Q1 		$2.22M Sell
8,055
-4,556
-36% -$1.67M ﹤0.01% 3776
2022
Q4 		$4.88M Buy
12,611
+6,642
+111% +$1.87M ﹤0.01% 3192
2022
Q3 		$1.43M Sell
5,969
-17,318
-74% -$4.64M ﹤0.01% 4254
2022
Q2 		$5.19M Buy
23,287
+11,152
+92% +$4.8M ﹤0.01% 3095
2022
Q1 		$8.26M Buy
12,135
+8,022
+195% +$4.83M ﹤0.01% 2879
2021
Q4 		$2.84M Sell
4,113
-5,213
-56% -$3.86M ﹤0.01% 3940
2021
Q3 		$6.92M Buy
9,326
+4,819
+107% +$3.28M ﹤0.01% 3072
2021
Q2 		$3.38M Buy
4,507
+460
+11% +$352K ﹤0.01% 3708
2021
Q1 		$3.3M Buy
4,047
+549
+16% +$424K ﹤0.01% 3511
2020
Q4 		$2.98M Sell
3,498
-1,195
-25% -$921K ﹤0.01% 3425
2020
Q3 		$3.52M Buy
+4,693
New +$3.85M ﹤0.01% 3160

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Goldman Sachs's OM Position: Q2 2026 in Review

Goldman Sachs increased its Outset Medical (OM) stake by 86% in Q2 2026, buying an estimated $350K and bringing the position to 173,460 shares worth $749K. The position accounts for ﹤0.01% of the portfolio, ranked #5436.

Goldman Sachs first reported a position in OM in Q3 2020 and has held it in 23 quarters since. The position peaked at $8.26M in Q1 2022. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Goldman Sachs held 173,460 shares of Outset Medical worth $749K as of Q2 2026.
  • Goldman Sachs bought 80,100 Outset Medical shares in Q2 2026, an estimated $350K.
  • Outset Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5436 holding.
  • Goldman Sachs first reported a position in Outset Medical in Q3 2020 and has held it in 23 quarters since.
  • Goldman Sachs's Outset Medical position peaked at $8.26M in Q1 2022.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.